638 results on '"CEVOLI, SABINA"'
Search Results
2. The Role of the Combination Paracetamol/Caffeine in Treatment of Acute Migraine Pain: A Narrative Review
3. Impact of multiple treatment cycles with anti-CGRP monoclonal antibodies on migraine course: focus on discontinuation periods. Insights from the multicenter, prospective, I-GRAINE study
4. Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study
5. Profiling iNPH features through cluster analysis: an aid for clinical suspicion and diagnosis
6. Long-Term Effectiveness of Galcanezumab in the Prevention of Migraine: An Italian Retrospective Analysis (REALITY)
7. Is physiotherapy in migraines known to sufferers? A cross-sectional study
8. Gender-related stress factors and emotional perception in migraine: a structured online questionnaire in migraine patients and controls
9. Migraine chronification as an allostatic disorder: a proof-of-concept study
10. Correction: The Role of the Combination Paracetamol/Caffeine in Treatment of Acute Migraine Pain: A Narrative Review
11. Correction to: Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study
12. Retreating migraine patients in the second year with monoclonal antibodies anti-CGRP pathway: the multicenter prospective cohort RE-DO study
13. Acupuncture as an alternative or in addition to conventional treatment for chronic non-specific low back pain: A systematic review and meta-analysis
14. Conversion from chronic to episodic migraine in patients treated with galcanezumab in real life in Italy: the 12-month observational, longitudinal, cohort multicenter GARLIT experience
15. The ultimate guide to the anti-CGRP monoclonal antibodies galaxy
16. Chronic migraine evolution after 3 months from erenumab suspension: real-world-evidence-life data
17. Great occipital nerve long-acting steroid injections in cluster headache therapy: an observational prospective study
18. Real-life assessment of erenumab in refractory chronic migraine with medication overuse headache
19. Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patients
20. In vivo assessment of Lewy body and beta-amyloid copathologies in idiopathic normal pressure hydrocephalus: prevalence and associations with clinical features and surgery outcome
21. Gait apraxia evaluation in normal pressure hydrocephalus using inertial sensors. Clinical correlates, ventriculoperitoneal shunt outcomes, and tap-test predictive capacity
22. Comparing the relative and absolute effect of erenumab: is a 50% response enough? Results from the ESTEEMen study
23. Improvement in diagnostic-therapeutic care pathways for women with migraine: an Italian Delphi panel.
24. Headache
25. Is There a Gender Difference in the Response to onabotulinumtoxinA in Chronic Migraine? Insights from a Real-Life European Multicenter Study on 2879 Patients
26. Spontaneous Intracranial Hypotension and Subdural Hematomas Treatment Management Using MMA Embolization and Target Blood Patch: A Case Report
27. Classification and Clinical Features
28. When should we consider chronic patients as non-responders to monoclonal antibodies targeting the CGRP pathway?
29. Intravenous immunoglobulin therapy in COVID-19-related encephalopathy
30. Premotor antidepressants use differs according to Parkinson's disease subtype: A cohort study
31. Early Management of OnabotulinumtoxinA Treatment in Chronic Migraine: Insights from a Real-Life European Multicenter Study
32. The first interim analysis of Italian patients enrolled in the real-world, Pan-European, prospective, observational, phase 4 PEARL study of fremanezumab effectiveness.
33. Central and Peripheral Nervous Disorders
34. Anterior Callosal Angle: A New Marker of Idiopathic Normal Pressure Hydrocephalus?
35. Is physiotherapy in migraines known to sufferers? A cross-sectional study
36. Gender-related stress factors and emotional perception in migraine: a structured online questionnaire in migraine patients and controls
37. Locking down the CGRP pathway during the COVID-19 pandemic lockdown: the PandeMig study
38. Discontinuing monoclonal antibodies targeting CGRP pathway after one-year treatment: an observational longitudinal cohort study
39. Nummular headache: a gender-oriented perspective on a case series from the RegistRare Network
40. Interobserver reliability of ICSD-3 diagnostic criteria for disorders of arousal in adults
41. State and trait anger and its expression in cluster headache compared with migraine: a cross-sectional study
42. A prospective evaluation of clinical and instrumental features before and after ventriculo-peritoneal shunt in patients with idiopathic Normal pressure hydrocephalus: The Bologna PRO-Hydro study
43. Headache
44. Erenumab efficacy in highly resistant chronic migraine: a real-life study
45. Drug withdrawal along with bridge therapy with methylprednisolone and/or diazepam for treatment of medication overuse headache: a preliminary report from the WASH-OUT study
46. Clinical and radiological prognostic factors in spontaneous intracranial hypotension: a case series
47. Acupuncture as an alternative or in addition to conventional treatment for chronic non-specific low back pain: Systematic review and meta-analysis
48. Illness perception in patients with migraine: An exploratory study in a tertiary care headache centre
49. Do anti-CGRP drugs have a role in migraine aura therapy?
50. The effects of cerebrospinal fluid tap-test on idiopathic normal pressure hydrocephalus: an inertial sensors based assessment
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.